Inherent Biosciences Raises Series A Funding Led By Propel Bio Partners To Redefine The Path To Parenthood By Elevating The Standard Of Care In Male Reproductive Health
Round Type
Series A
Salt Lake CityBiotechnologyHealth CareGeneticsTherapeuticsDescription
Inherent Biosciences, the first Utah company involved in commercializing a diagnostic in the emerging biotech field of epigenetics, has raised Series A funding from an investor group led by Los Angeles-based Propel Bio Partners toward Inherent's goal of changing the course of reproductive health.
Quick answer
Inherent Biosciences raised an undisclosed amount in a Series A round, dated September 7, 2022. Inherent Biosciences is based in Salt Lake City, Utah, United States.
- How much did Inherent Biosciences raise?
- Inherent Biosciences raised an undisclosed amount in a Series A round on September 7, 2022.
- What does Inherent Biosciences do?
- Inherent Biosciences is pioneering epigenetic medicine for complex diseases.
- Where is Inherent Biosciences based and how big is it?
- Inherent Biosciences is based in Salt Lake City, Utah, United States.
- Who are the decision-makers at Inherent Biosciences?
- Fundz holds 1 contact at Inherent Biosciences, including the Co-founder, CEO . Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as Inherent Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Photys Therapeutics raised $75M (Series A) on September 8, 2022.
- MeiraGTx Holdings plc raised an undisclosed amount (Debt Financing) on August 3, 2022.
- Elevation Oncology raised $50M (Debt Financing) on July 28, 2022.
- Insmed Incorporated raised an undisclosed amount (Funding Round) on October 19, 2022.
- Orionis Biosciences raised $55M (Funding Round) on October 19, 2022.
- Viome raised $67M (Series C) on October 18, 2022.
Who to call at Inherent Biosciences, and when
A new round usually means Inherent Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Inherent Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inherent Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inherent Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Inherent Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansInherent Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.